2m 2m 2m 2m 2m 2m 2m
AKANDA (AKAN)
NASDAQ
$5.48+$0.17 (+3.11%)
Price as of Aug 03, 2026 10:23 AM EDT- $2.9MMarket Cap
- -93.13%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AKANDA (AKAN)
$5.48+$0.17 (+3.11%)
AKAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.31 | ||
Change | -$1.08 (-16.90%) | ||
Open | $6.08 | ||
High | $6.12 | ||
Low | $5.14 | ||
Previous Close | $6.39 | ||
Volume | 89,943 | ||
30-Day Average Volume | 314,913 | ||
1-Week Change | -31.31% | ||
1-Month Change | -61.27% | ||
1-Year Change | -93.13% | ||
3-Year Change | -99.85% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 540,841 | ||
Total Assets | $6.2M | ||
Market Cap | $2.9M | ||
Enterprise Value | $3.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4.5 | ||
Last Split Date | 04/13/2026 | ||
Earnings & Revenue